Grant Details
Grant Number: |
5U24CA078134-05 Interpret this number |
Primary Investigator: |
Anton-Culver, Hoda |
Organization: |
University Of California Irvine |
Project Title: |
Uci Ucsd Cancer Genetics Network |
Fiscal Year: |
2002 |
Abstract
DESCRIPTION: (Applicant's Description) Newly emerging technology for
mutation detection and high-throughput sequencing of genes will make
obsolete many of the previous and some of the current research strategies in
the genetic epidemiology of cancer. The proposed UCI-UCSD Cancer Genetics
Network (UCI-UCSD CGN) will be accomplished through the existing strengths
of its co-investigators, community clinicians, existing resources, and
previous experience in genetic epidemiology of cancer. Fundamental to the
new NCI direction is the participation of clinicians, the community they
serve, and basic scientists and epidemiologists. Also integral to the
strategy is the dissemination of the growing body of genetic information to
all participants and the provision of genetic counseling to those affected
by the discovery of cancer mutations.
The UCI-UCSD CGN will serve as an infrastructure for collaborative research
investigations into the genetic basis of human cancer susceptibility. 1)
The infrastructure will include basic network activities. These activities
include the recruitment and follow-up of Network Participants, the
collection and storage of core information, the maintenance of a local
informatics system, a core laboratory for the processing and storage of
biological specimens for specific projects, and the maintenance of
informatics and communications technology to interface with the Nationwide
Network. The UCI-- UCSD CGN will recruit potential enrollees from a total
population of approximately 264,450 individuals. This population will
include individuals at high-risk for cancer due to family history, members
of the VA Desert Pacific Health Care Network, cancer patients including
those with multiple primary cancer from the Cancer Surveillance Program of
Orange, San Diego, and Imperial Counties, referrals from community clinics,
physicians, and hospitals, and cancer survivors who are members of advocacy
and community groups. Once enrolled, network members will complete a
one-page interview of basic family history and risk factor information and
will be followed annually. Genetic counseling and education will be made
available to network members and referral physicians. 2) UCI-UCSD CGN will
expand research capabilities to support Network activities, specifically in
areas of molecular genetics, clinical genetics, genetic counseling, and
education. A network of top quality principal investigators and
co-investigators will provide an infrastructure for joint research efforts
between scientists and clinicians. The UCI-UCSD CGN will sponsor scientific
seminars and conferences that will facilitate the translation of molecular
genetics research into clinical practice. The majority of the elements of
the proposed network have already been established by our group and
communications among them are in place.
Publications
Early Detection of Ovarian Cancer using the Risk of Ovarian Cancer Algorithm with Frequent CA125 Testing in Women at Increased Familial Risk - Combined Results from Two Screening Trials.
Authors: Skates S.J.
, Greene M.H.
, Buys S.S.
, Mai P.L.
, Brown P.
, Piedmonte M.
, Rodriguez G.
, Schorge J.O.
, Sherman M.
, Daly M.B.
, et al.
.
Source: Clinical cancer research : an official journal of the American Association for Cancer Research, 2017-07-15; 23(14), p. 3628-3637.
EPub date: 2017-01-31.
PMID: 28143870
Related Citations
Long-term risk of medical conditions associated with breast cancer treatment.
Authors: Hill D.A.
, Horick N.K.
, Isaacs C.
, Domchek S.M.
, Tomlinson G.E.
, Lowery J.T.
, Kinney A.Y.
, Berg J.S.
, Edwards K.L.
, Moorman P.G.
, et al.
.
Source: Breast cancer research and treatment, 2014 May; 145(1), p. 233-43.
EPub date: 2014-04-03.
PMID: 24696430
Related Citations
Meat consumption, ornithine decarboxylase gene polymorphism, and outcomes after colorectal cancer diagnosis.
Authors: Zell J.A.
, Lin B.S.
, Ziogas A.
, Anton-Culver H.
.
Source: Journal of carcinogenesis, 2012; 11, p. 17.
EPub date: 2012-11-28.
PMID: 23233821
Related Citations
Activating mutation in MET oncogene in familial colorectal cancer.
Authors: Neklason D.W.
, Done M.W.
, Sargent N.R.
, Schwartz A.G.
, Anton-Culver H.
, Griffin C.A.
, Ahnen D.J.
, Schildkraut J.M.
, Tomlinson G.E.
, Strong L.C.
, et al.
.
Source: BMC cancer, 2011-10-04; 11, p. 424.
EPub date: 2011-10-04.
PMID: 21970370
Related Citations
Large prospective study of ovarian cancer screening in high-risk women: CA125 cut-point defined by menopausal status.
Authors: Skates S.J.
, Mai P.
, Horick N.K.
, Piedmonte M.
, Drescher C.W.
, Isaacs C.
, Armstrong D.K.
, Buys S.S.
, Rodriguez G.C.
, Horowitz I.R.
, et al.
.
Source: Cancer prevention research (Philadelphia, Pa.), 2011 Sep; 4(9), p. 1401-8.
PMID: 21893500
Related Citations
Clinically relevant changes in family history of cancer over time.
Authors: Ziogas A.
, Horick N.K.
, Kinney A.Y.
, Lowery J.T.
, Domchek S.M.
, Isaacs C.
, Griffin C.A.
, Moorman P.G.
, Edwards K.L.
, Hill D.A.
, et al.
.
Source: JAMA, 2011-07-13; 306(2), p. 172-8.
PMID: 21750294
Related Citations
Associations of a polymorphism in the ornithine decarboxylase gene with colorectal cancer survival.
Authors: Zell J.A.
, Ziogas A.
, Ignatenko N.
, Honda J.
, Qu N.
, Bobbs A.S.
, Neuhausen S.L.
, Gerner E.W.
, Anton-Culver H.
.
Source: Clinical cancer research : an official journal of the American Association for Cancer Research, 2009-10-01; 15(19), p. 6208-16.
EPub date: 2009-09-29.
PMID: 19789310
Related Citations
Common familial colorectal cancer linked to chromosome 7q31: a genome-wide analysis.
Authors: Neklason D.W.
, Kerber R.A.
, Nilson D.B.
, Anton-Culver H.
, Schwartz A.G.
, Griffin C.A.
, Lowery J.T.
, Schildkraut J.M.
, Evans J.P.
, Tomlinson G.E.
, et al.
.
Source: Cancer research, 2008-11-01; 68(21), p. 8993-7.
PMID: 18974144
Related Citations
BRAF polymorphisms and the risk of ovarian cancer of low malignant potential.
Authors: Kelemen L.
, James M.
, Spurdle A.
, Campbell I.
, Chang-Claude J.
, Peel D.
, Anton-Culver H.
, Berchuck A.
, Schildkraut J.
, Whittemore A.
, et al.
.
Source: Gynecologic oncology, 2005 Jun; 97(3), p. 807-12.
PMID: 15904951
Related Citations
Validation of family history data in cancer family registries.
Authors: Ziogas A.
, Anton-Culver H.
.
Source: American journal of preventive medicine, 2003 Feb; 24(2), p. 190-8.
PMID: 12568826
Related Citations